Cdk5 Modulation of mitogen-activated protein kinase signaling regulates neuronal survival

Ya-Li Zheng1, Bing-Sheng Li, Jyotshna Kanungo

  • 1Laboratory of Neurochemistry, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.

Insights

Cyclin-dependent kinase 5 (Cdk5) tightly regulates mitogen-activated protein kinase signaling, crucial for neuronal survival. Dysregulation leads to apoptosis, highlighting Cdk5

Area of Science:

  • Neuroscience
  • Cell Biology
  • Molecular Biology

Background:

  • Cyclin-dependent kinase 5 (Cdk5) plays a vital role in neuronal development, migration, and survival.
  • Cdk5 interacts with apoptotic and survival pathways, influencing neuronal cell fate.
  • Previous studies indicated Cdk5-mediated phosphorylation of MEK1 inhibits NGF-induced transient activation in PC12 cells.

Purpose of the Study:

  • To investigate the kinetics of NGF-induced extracellular signal-regulated kinase (Erk)1/2 activation in cortical neurons.
  • To determine the effect of Cdk5 inhibition on Erk1/2 activation and neuronal survival.
  • To elucidate the role of Cdk5 in modulating the mitogen-activated protein kinase pathway for cortical neuron survival.

Main Methods:

  • Studied NGF activation kinetics of Erk1/2 in cortical neurons.
  • Utilized roscovitine, a Cdk5 inhibitor, and PD98095, a MEK1 inhibitor.
  • Employed Cdk5 small interference RNA (siRNA) to knock down Cdk5 activity.
  • Assessed apoptosis and changes in phosphorylated tau and neurofilament localization.

Main Results:

  • NGF induced transient Erk1/2 activation, peaking at 15 min and declining rapidly.
  • Cdk5 inhibition with roscovitine led to sustained Erk1/2 activation for 48 h.
  • Sustained Erk1/2 activation induced apoptosis in cortical neurons.
  • MEK1 inhibition (PD98095) prevented roscovitine-induced apoptosis.
  • Cdk5 knockdown confirmed these findings, correlating apoptosis with altered tau and neurofilament distribution.

Conclusions:

  • Cortical neuron survival depends on Cdk5's precise modulation of the mitogen-activated protein kinase pathway.
  • Aberrant Cdk5 activity disrupts Erk1/2 signaling, promoting apoptosis.
  • Cdk5 acts as a critical regulator, balancing neuronal survival signals.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...